UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

EBV+ tumors exploit tumor cell-intrinsic and -extrinsic mechanisms to produce regulatory T cell-recruiting chemokines CCL17 and CCL22

PLoS pathogens, 2022-01, Vol.18 (1), p.e1010200-e1010200

2022

Volltextzugriff (PDF)

Proteome-wide analysis of CD8+ T cell responses to EBV reveals differences between primary and persistent infection

PLoS pathogens, 2018-09, Vol.14 (9), p.e1007110-e1007110

2018

Volltextzugriff (PDF)

A distinct subpopulation of human NK cells restricts B cell transformation by EBV

The Journal of immunology (1950), 2013-11, Vol.191 (10), p.4989-4995

2013

Volltextzugriff (PDF)

Autophagy Proteins in Phagocyte Endocytosis and Exocytosis

Frontiers in immunology, 2017-09, Vol.8, p.1183-1183

Münz, Christian

2017

Volltextzugriff (PDF)

Natural Killer Cell Responses during Human γ-Herpesvirus Infections

Vaccines (Basel), 2021-06, Vol.9 (6), p.655

Münz, Christian

2021

Volltextzugriff (PDF)

Human γ-Herpesvirus Infection, Tumorigenesis, and Immune Control in Mice with Reconstituted Human Immune System Components

Frontiers in immunology, 2018-02, Vol.9, p.238-238

Münz, Christian

2018

Volltextzugriff (PDF)

Attenuated immune control of Epstein–Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA‐DR15

European journal of immunology, 2021-01, Vol.51 (1), p.64-75

2021

Volltextzugriff (PDF)

CD8+ T cells retain protective functions despite sustained inhibitory receptor expression during Epstein-Barr virus infection in vivo

PLoS pathogens, 2019-05, Vol.15 (5), p.e1007748-e1007748

2019

Volltextzugriff (PDF)

Editorial: EBV-induced T cell immunity in cancers

Frontiers in immunology, 2024-07, Vol.15, p.1454792

2024

Volltextzugriff (PDF)

MHC class II‐deficient mice allow functional human CD4+ T‐cell development

European journal of immunology, 2023-07, Vol.53 (7), p.e2250313-n/a

2023

Volltextzugriff (PDF)

Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and γδ T cells

The Journal of experimental medicine, 2017-06, Vol.214 (6), p.1827-1841

2017

Volltextzugriff (PDF)

Infectious diseases in humanized mice

European journal of immunology, 2013-09, Vol.43 (9), p.2246-2254

2013

Volltextzugriff (PDF)

Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice

PLoS pathogens, 2020-04, Vol.16 (4), p.e1008477-e1008477

2020

Volltextzugriff (PDF)

Kaposi Sarcoma-Associated Herpesvirus Infection and Endemic Burkitt Lymphoma

The Journal of infectious diseases, 2020-06, Vol.222 (1), p.111-120

2020

Volltextzugriff (PDF)

Innate immune responses against Epstein Barr virus infection

Journal of leukocyte biology, 2013-12, Vol.94 (6), p.1185-1190

2013

Volltextzugriff (PDF)

Regulatory T Cells in Endemic Burkitt Lymphoma Patients Are Associated with Poor Outcomes: A Prospective, Longitudinal Study

PloS one, 2016-12, Vol.11 (12), p.e0167841-e0167841

2016

Volltextzugriff (PDF)

Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and gamma delta T cells

The Journal of experimental medicine, 2017-06, Vol.214 (6), p.1827-1841

2017

Volltextzugriff (PDF)

EBV persistence without its EBNA3A and 3C oncogenes in vivo

PLoS pathogens, 2018-04, Vol.14 (4), p.e1007039

2018

Volltextzugriff (PDF)

Latent Membrane Protein 2 (LMP2)

Current topics in microbiology and immunology, 2015, Vol.391, p.151

2015

Volltextzugriff (PDF)

Immune Control and Vaccination against the Epstein-Barr Virus in Humanized Mice

Vaccines (Basel), 2019-12, Vol.7 (4), p.217

Münz, Christian

2019

Volltextzugriff (PDF)

Dendritic cells initiate immune control of epstein-barr virus transformation of B lymphocytes in vitro

The Journal of experimental medicine, 2003-12, Vol.198 (11), p.1653-1663

2003

Volltextzugriff (PDF)

Cellular immune controls over Epstein–Barr virus infection: new lessons from the clinic and the laboratory

Trends in immunology, 2014-04, Vol.35 (4), p.159-169

2014

Volltextzugriff (PDF)

EBV in MS: guilty by association?

Trends in immunology, 2009-06, Vol.30 (6), p.243-248

2009

Volltextzugriff (PDF)

Epstein-barr virus nuclear antigen 1: from immunologically invisible to a promising T cell target

The Journal of experimental medicine, 2004-05, Vol.199 (10), p.1301-1304

Muenz, C

2004

Volltextzugriff (PDF)

Priming of protective T cell responses against virus-induced tumors in mice with human immune system components

The Journal of experimental medicine, 2009-06, Vol.206 (6), p.1423-1434

2009

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Aktive Filter

ThemaEpstein-Barr Virus

ThemaImmunology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(30)
Buchkapitel
(1)

Sprache

Englisch
(31)

Erscheinungsjahr

n.n

Thema

Science & Technology
(27)
Life Sciences & Biomedicine
(26)
Humans
(24)
Herpesvirus 4, Human - Immunology
(15)
Animals
(12)
Infections
(12)
Lymphocytes
(11)
Lymphocytes T
(11)
Epstein-Barr Virus Infections - Immunology
(10)
Immune System
(10)
Lymphoma
(10)
Mice
(10)
Medicine, Research & Experimental
(8)
Proteins
(8)
Research & Experimental Medicine
(8)
T Cells
(8)
Viruses
(8)
Antigens
(7)

13 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

EBV+ tumors exploit tumor cell-intrinsic and -extrinsic mechanisms to produce regulatory T cell-recruiting chemokines CCL17 and CCL22

Proteome-wide analysis of CD8+ T cell responses to EBV reveals differences between primary and persistent infection

A distinct subpopulation of human NK cells restricts B cell transformation by EBV

Autophagy Proteins in Phagocyte Endocytosis and Exocytosis

Natural Killer Cell Responses during Human γ-Herpesvirus Infections

Human γ-Herpesvirus Infection, Tumorigenesis, and Immune Control in Mice with Reconstituted Human Immune System Components

Attenuated immune control of Epstein–Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA‐DR15

CD8+ T cells retain protective functions despite sustained inhibitory receptor expression during Epstein-Barr virus infection in vivo

Editorial: EBV-induced T cell immunity in cancers

MHC class II‐deficient mice allow functional human CD4+ T‐cell development

Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and γδ T cells

Infectious diseases in humanized mice

Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice

Kaposi Sarcoma-Associated Herpesvirus Infection and Endemic Burkitt Lymphoma

Innate immune responses against Epstein Barr virus infection

Regulatory T Cells in Endemic Burkitt Lymphoma Patients Are Associated with Poor Outcomes: A Prospective, Longitudinal Study

Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and gamma delta T cells

EBV persistence without its EBNA3A and 3C oncogenes in vivo

Latent Membrane Protein 2 (LMP2)

Immune Control and Vaccination against the Epstein-Barr Virus in Humanized Mice

Dendritic cells initiate immune control of epstein-barr virus transformation of B lymphocytes in vitro

Cellular immune controls over Epstein–Barr virus infection: new lessons from the clinic and the laboratory

EBV in MS: guilty by association?

Epstein-barr virus nuclear antigen 1: from immunologically invisible to a promising T cell target

Priming of protective T cell responses against virus-induced tumors in mice with human immune system components

Aktive Filter

Suchergebnisse filtern